ALLMedicine™ Heart Failure Center

Sep 15th, 2021 - Identification of patients with cardiogenic shock and right ventricle (RV) dysfunction who may require biventricular rather than isolated left ventricular (LV) support remains challenging. In this setting, rigorous hemodynamic evaluation of bivent...

Sep 15th, 2021 - The Dilemma of Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction: Are We Waiting Too Long to Intervene, or Should We Wait for More Evidence?|2021|Cormican DS,Czerny M,Ramakrishna H,|

Sep 15th, 2021 - Excessive activation of the sympathetic nervous system is one of the pathophysiological hallmarks of hypertension and heart failure. Within the central nervous system, the paraventricular nucleus (PVN) of the hypothalamus and the rostral ventrolat...

Sep 15th, 2021 - We evaluated the prognostic value of changes in perfusion defect size (PDS) on serial MPS in patients treated with primary percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). We enrolled 112 patients treated with prim...

Sep 15th, 2021 - Recent research highlighted the potential role of circulating cell-free DNA (cfDNA), resulted by apoptosis or cell necrosis, as a prognostic marker in the setting of different clinical conditions. Cardiorenal syndrome type 1 (CRS type 1) is charac...

Jul 18th, 2021 - 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.|2021|Bakaeen FG,Gaudino M,Whitman G,Doenst T,Ruel M,|standards,diagnostic im...

Apr 28th, 2021 - Hypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardia...

Apr 27th, 2021 - The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings...

Apr 9th, 2021 - In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we provide comprehensive recommendations and practical tips for the pharmacologic management of patients with HF with reduced ejection fraction (HFrEF). Since the...

Jan 16th, 2021 - 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set...

Sep 9th, 2021 - Purpose and Rationale: Pleural effusion is a common presentation in patients with heart failure, and the condition is related to a poor prognosis and increased mortality. Therapeutic options consist of intensification of diuretic treatment and inv...

Sep 8th, 2021 - Prospective, unblinded, randomized (1:1), single-center pilot study of 40 patients allocated to one of the treatment arms (OMT + empaglifozin or OMT). Strategies to reduce Contrast-induced acute kidney injury will be used in both study arms The st...

Sep 8th, 2021 - Atrial fibrillation (AF) is the most common arrhythmia worldwide. It carries a significant health burden, conferring on sufferers a reduction in quality of life, risk of significant morbidities such as stroke and heart failure, and significant mor...

Sep 5th, 2021 - Era of COVID-19 and the related panic lead to widely spread antibiotics misuse especially for azithromycin. Cross sensitivity between azithromycin and clarithromycin can impact success rates of H. pylori treatment regimens.(1) Here we aim to explo...

Sep 5th, 2021 - This will be a prospective multi-methods observational study. We will assess the feasibility of the novel home-based remote physiological monitoring (RPM) system paired to a smartphone app (Sphygmo™) and linked to a secure physician platform. We w...

Jul 20th, 2021 - This transcript has been edited for clarity. The story of cardiovascular outcomes in diabetes is a fascinating one. There were new developments in the regulatory landscape that really drove the past 10 years of history. If you go way back to the f...

Jul 15th, 2021 - The increased prevalence of type 2 diabetes and heart failure highlights the need for optimal strategies for comanaging these diseases. An estimated 26.9 million Americans, or 8.2% of the US population, have diabetes; an additional 6.2 million hav...

Jul 12th, 2021 - Treatment with darolutamide (Nubeqa) induced a low cumulative incidence of hormone treatment–related adverse effects (HTR AEs) that was comparable to treatment with placebo in patients with nonmetastatic castration-resistant prostate cancer (CRPC)...

Jul 12th, 2021 - Secondary mitral regurgitation (sMR) is common in patients with heart failure (HF) and is associated with increased mortality, but it is undertreated, according to a new study. Investigators analyzed data from more than 13,000 HF patients in an Au...

Jul 8th, 2021 - Intravenous iron therapy was predicted to be highly cost-effective or even cost-saving when used in high-risk, iron-deficient patients with heart failure (HF) in each of four different countries with different healthcare payment systems, in an ana...